GT Biopharma, Inc. (GTBP)
NASDAQ · Healthcare
GT Biopharma, Inc. Shareholder Equity 2010–2020
GT Biopharma, Inc. annual/quarterly shareholder equity history from 2010 to 2020. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- GT Biopharma, Inc. shareholder equity for the quarter ending December 31, 2020 were -29.4M, a 52.42% increase year-over-year.
- GT Biopharma, Inc. shareholder equity for 2020 were -29.4M, a 52.42% increase from 2019.
- GT Biopharma, Inc. shareholder equity for 2019 were -19.3M, a 107.67% decrease from 2017.
- GT Biopharma, Inc. shareholder equity for 2017 were 251.7M, a 1430.00% decrease from 2016.
- GT Biopharma, Inc. shareholder equity for 2016 were -18.9M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| GT Biopharma, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2020 | $-29 |
| 2019 | $-19 |
| 2017 | $252 |
| 2016 | $-19 |
| 2015 | $-51 |
| 2014 | $-30 |
| 2013 | $-6 |
| 2012 | $-6 |
| 2011 | $-5 |
| 2010 | $-5 |
| GT Biopharma, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2020-12-31 | $-29 |
| 2019-12-31 | $-19 |
| 2017-12-31 | $252 |
| 2016-12-31 | $-19 |
| 2015-12-31 | $-51 |
| 2014-12-31 | $-30 |
| 2013-12-31 | $-6 |
| 2012-12-31 | $-6 |
| 2011-12-31 | $-5 |
| 2010-12-31 | $-5 |
GT Biopharma, Inc. Shareholder Equity — FAQ
GT Biopharma, Inc. (GTBP) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GTBP's shareholder equity history?
The chart and table above show GT Biopharma, Inc.'s shareholder equity by year and by quarter, including the growth rate.